Iris Nederlof

2.2k total citations
15 papers, 317 citations indexed

About

Iris Nederlof is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Iris Nederlof has authored 15 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Iris Nederlof's work include Cancer Immunotherapy and Biomarkers (9 papers), Immune cells in cancer (4 papers) and Single-cell and spatial transcriptomics (2 papers). Iris Nederlof is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Immune cells in cancer (4 papers) and Single-cell and spatial transcriptomics (2 papers). Iris Nederlof collaborates with scholars based in Netherlands, Belgium and United States. Iris Nederlof's co-authors include Hugo M. Horlings, Jonas Teuwen, Efstratios Gavves, Marleen Kok, Leonie Voorwerk, Roberto Salgado, Renée Foekens, Marcel Smid, Olga I. Isaeva and Anita Trapman-Jansen and has published in prestigious journals such as Nature Communications, Cancer Research and Clinical Cancer Research.

In The Last Decade

Iris Nederlof

15 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iris Nederlof Netherlands	9	150	138	71	57	51	15	317
Katja Välimäki Finland	8	128 0.9×	74 0.5×	100 1.4×	53 0.9×	18 0.4×	16	296
Tasuku Mariya Japan	11	227 1.5×	109 0.8×	257 3.6×	117 2.1×	24 0.5×	47	536
Tomohiro Kikuchi Japan	10	170 1.1×	121 0.9×	181 2.5×	79 1.4×	20 0.4×	54	443
Veronika Kloboves Prevodnik Slovenia	10	130 0.9×	60 0.4×	50 0.7×	31 0.5×	9 0.2×	30	325
Ashley Kiemen United States	9	87 0.6×	30 0.2×	98 1.4×	39 0.7×	45 0.9×	23	270
Jiamei Chen China	13	107 0.7×	41 0.3×	94 1.3×	69 1.2×	83 1.6×	25	350
Geoff Watson Australia	9	187 1.2×	44 0.3×	93 1.3×	31 0.5×	19 0.4×	17	384
Guangdong Qiao China	9	97 0.6×	95 0.7×	105 1.5×	84 1.5×	12 0.2×	31	264
Simona Pigozzi Italy	9	121 0.8×	61 0.4×	101 1.4×	51 0.9×	7 0.1×	24	320
Banri Tsuda Japan	10	191 1.3×	139 1.0×	77 1.1×	63 1.1×	7 0.1×	27	333

Countries citing papers authored by Iris Nederlof

Since Specialization

Citations

This map shows the geographic impact of Iris Nederlof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Nederlof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Nederlof more than expected).

Fields of papers citing papers by Iris Nederlof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Nederlof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Nederlof. The network helps show where Iris Nederlof may publish in the future.

Co-authorship network of co-authors of Iris Nederlof

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Nederlof. A scholar is included among the top collaborators of Iris Nederlof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Nederlof. Iris Nederlof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Bakker, Noor A. M., Hannah Garner, Ewald van Dyk, et al.. (2025). Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality. npj Breast Cancer. 11(1). 5–5. 4 indexed citations

Nederlof, Iris, Gil Awada, Hugo M. Horlings, et al.. (2024). LBA11 Neoadjuvant nivolumab/relatlimab or nivolumab/ipilimumab in triple negative breast cancer with high tumor-infiltrating lymphocytes (TILs). Annals of Oncology. 35. S1206–S1206. 3 indexed citations

Greenwald, Noah F., Iris Nederlof, Hugo M. Horlings, et al.. (2024). Abstract 3894: The temporal influence of the tumor microenvironment in response to checkpoint blockade. Cancer Research. 84(6_Supplement). 3894–3894. 1 indexed citations

Nederlof, Iris, Leonie Voorwerk, & Marleen Kok. (2023). Facts and Hopes in Immunotherapy for Early-Stage Triple-Negative Breast Cancer. Clinical Cancer Research. 29(13). 2362–2370. 9 indexed citations

Isaeva, Olga I., Iris Nederlof, Bram Boeckx, et al.. (2023). 163MO Single-cell T cell dynamics induced by neoadjuvant nivolumab +/- ipilimumab in early triple negative breast cancer with tumor-infiltrating lymphocytes (BELLINI trial). Immuno-Oncology Technology. 20. 100622–100622. 1 indexed citations

Nederlof, Iris, Shan E Ahmed Raza, Khalid AbdulJabbar, et al.. (2022). Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer. npj Breast Cancer. 8(1). 56–56. 8 indexed citations

Gavves, Efstratios, et al.. (2022). DeepSMILE: Contrastive self-supervised pre-training benefits MSI and HRD classification directly from H&E whole-slide images in colorectal and breast cancer. Medical Image Analysis. 79. 102464–102464. 79 indexed citations

Hammerl, Dora, John W.M. Martens, Mieke Timmermans, et al.. (2021). Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer. Nature Communications. 12(1). 5668–5668. 135 indexed citations

Nederlof, Iris, Christine Desmedt, Roberto Salgado, et al.. (2021). 3O Spatial analysis of lymphocytes and fibroblasts identifies biological relevant patterns in estrogen receptor positive breast cancer. Annals of Oncology. 32. S22–S23. 1 indexed citations

10.

Nederlof, Iris, Hugo M. Horlings, Christina Curtis, & Marleen Kok. (2021). A High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer. Cancers. 13(2). 316–316. 13 indexed citations

11.

Nederlof, Iris, J.J.M. Drabbels, Jacqueline D.H. Anholts, et al.. (2019). Increased HLA-G Expression in Term Placenta of Women with a History of Recurrent Miscarriage Despite Their Genetic Predisposition to Decreased HLA-G Levels. International Journal of Molecular Sciences. 20(3). 625–625. 17 indexed citations

12.

Nederlof, Iris, Caroline A. Lindemans, Marc Bierings, et al.. (2019). Recognizing a Non‐classical Telomeropathy before Hematopoietic Stem Cell Transplantation in Pediatric Patients: A Case Series. HemaSphere. 3(4). e282–e282. 3 indexed citations

13.

Joosse, Maria E., Iris Nederlof, Lucy S. K. Walker, & Janneke N. Samsom. (2018). Tipping the balance: inhibitory checkpoints in intestinal homeostasis. Mucosal Immunology. 12(1). 21–35. 10 indexed citations

14.

Stikvoort, Arwen, Ahmed Gaballa, Iris Nederlof, et al.. (2017). Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft Composition. Biology of Blood and Marrow Transplantation. 24(3). 467–477. 13 indexed citations

15.

Nederlof, Iris, Tess Meuleman, Marie‐Louise van der Hoorn, Frans H.J. Claas, & Michael Eikmans. (2017). The seed to success: The role of seminal plasma in pregnancy. Journal of Reproductive Immunology. 123. 24–28. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact